Cilostazol synergistically inhibits proinflammatory cytokines by activating IL-10 and suppressing cytokine signaling 3 in RA-SFs when used in combination with celecoxib for RA treatment [143]. The gene discussed is IL10; the disease is rheumatoid arthritis.